Rhythm Pharmaceuticals stockholders elect two Class III directors, ratify auditor, approve say-on-pay

RHYTHM PHARMACEUTICALS, INC.

David W.J. McGirr elected with 53.2M votes for, 8.7M withheld; David P. Meeker with 60.0M for, 1.9M withheld.
Ratification of Ernst & Young as FY2026 auditor approved: 63.9M for, 197.7K against, 23.6K abstained.
Advisory approval of named executive officer compensation: 50.4M for, 11.5M against, 36.7K abstained.
Total eligible votes 69.7M; 64.1M votes present (92% of eligible).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.